These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

906 related articles for article (PubMed ID: 18655790)

  • 21. Plasma biomarkers of acute attacks in patients with angioedema due to C1-inhibitor deficiency.
    Cugno M; Zanichelli A; Bellatorre AG; Griffini S; Cicardi M
    Allergy; 2009 Feb; 64(2):254-7. PubMed ID: 19076541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glomerulonephritis and hereditary angioedema: report of 2 cases.
    Hory B; Haultier JJ
    Clin Nephrol; 1989 May; 31(5):259-63. PubMed ID: 2736814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic analysis of human plasma-derived pasteurized C1-inhibitor concentrate in adults and children with hereditary angioedema: a prospective study.
    Martinez-Saguer I; Rusicke E; Aygören-Pürsün E; von Hentig N; Klingebiel T; Kreuz W
    Transfusion; 2010 Feb; 50(2):354-60. PubMed ID: 19788511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overview of hereditary angioedema caused by C1-inhibitor deficiency: assessment and clinical management.
    Bork K; Davis-Lorton M
    Eur Ann Allergy Clin Immunol; 2013 Feb; 45(1):7-16. PubMed ID: 23678554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis and management of hereditary angioedema: an American approach.
    Zuraw BL
    Transfus Apher Sci; 2003 Dec; 29(3):239-45. PubMed ID: 14572816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The C1 inhibitor deficiency. A review.
    Carreer FM
    Eur J Clin Chem Clin Biochem; 1992 Dec; 30(12):793-807. PubMed ID: 1489854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emergency treatment of acute attacks in hereditary angioedema due to C1 inhibitor deficiency: what is the evidence?
    Longhurst HJ
    Int J Clin Pract; 2005 May; 59(5):594-9. PubMed ID: 15857357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hereditary angioedema. Effect of danazol on C4 and functional C1INH].
    Fabiani JE; Paulin P; Simkin G; Leoni J; Palombarani S; Squiquera L
    Rev Alerg Mex (1987); 1989; 36(3):99-104. PubMed ID: 2772500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parallel comparison of three methodologies for measuring functional C1-inhibitor in Hereditary angioedema patients.
    Kapoor A; Garg BK; Zhou Z; Lu P; Chockalingam PS
    Int Immunopharmacol; 2020 Apr; 81():106348. PubMed ID: 32143147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema.
    Binkley KE; Davis A
    J Allergy Clin Immunol; 2000 Sep; 106(3):546-50. PubMed ID: 10984376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C1-inhibitor deficiency and angioedema.
    Carugati A; Pappalardo E; Zingale LC; Cicardi M
    Mol Immunol; 2001 Aug; 38(2-3):161-73. PubMed ID: 11532278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical problems in the C1-inhibitor deficient patient.
    Agostoni A; Cicardi M; Cugno M; Storti E
    Behring Inst Mitt; 1993 Dec; (93):306-12. PubMed ID: 8172581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hereditary angioedema with normal C1-inhibitor activity in women.
    Bork K; Barnstedt SE; Koch P; Traupe H
    Lancet; 2000 Jul; 356(9225):213-7. PubMed ID: 10963200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of chromogenic and ELISA functional C1 inhibitor tests in diagnosing hereditary angioedema.
    Li HH; Busse P; Lumry WR; Frazer-Abel A; Levy H; Steele T; Dayno J; Riedl M
    J Allergy Clin Immunol Pract; 2015; 3(2):200-5. PubMed ID: 25609336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Perioperative treatment of a patient with hereditary angioedema (HAE) in a case of a young patient with osteosynthesis from a femoral fracture].
    Eckert S; Eifrig B; Standl T
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2000 Dec; 35(12):776-81. PubMed ID: 11194524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response of variant hereditary angioedema phenotypes to danazol therapy. Genetic implications.
    Gadek JE; Hosea SW; Gelfand JA; Frank MM
    J Clin Invest; 1979 Jul; 64(1):280-6. PubMed ID: 376558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoantibody facilitated cleavage of C1-inhibitor in autoimmune angioedema.
    Jackson J; Sim RB; Whaley K; Feighery C
    J Clin Invest; 1989 Feb; 83(2):698-707. PubMed ID: 2536404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis and treatment of hereditary angioedema.
    Canonica GW; Rossi O
    Panminerva Med; 2012 Sep; 54(3):241-53. PubMed ID: 22801442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency.
    Caballero T; Farkas H; Bouillet L; Bowen T; Gompel A; Fagerberg C; Bjökander J; Bork K; Bygum A; Cicardi M; de Carolis C; Frank M; Gooi JH; Longhurst H; Martínez-Saguer I; Nielsen EW; Obtulowitz K; Perricone R; Prior N;
    J Allergy Clin Immunol; 2012 Feb; 129(2):308-20. PubMed ID: 22197274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How do we treat patients with hereditary angioedema.
    Cicardi M; Zingale L
    Transfus Apher Sci; 2003 Dec; 29(3):221-7. PubMed ID: 14572813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.